@kristina.maay's testosterone for women claims, fact-checked
Quick answer
Testosterone therapy for postmenopausal women has evidence only for treating hypoactive sexual desire disorder, with studies showing improvement in sexual function at 300 micrograms daily transdermal dosing. The 2019 Global Consensus Position Statement found insufficient evidence for other claimed benefits like energy or mood improvement.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What does this TikTok actually claim?
Kristina Maay tells her 489,000 viewers that estrogen and progesterone HRT wasn't enough for her menopause symptoms. She suggests testosterone might be the missing piece but stays vague about specifics.
The video doesn't make explicit medical claims. Instead, it teases future content about testosterone benefits for women. This approach lets creators hint at health advice without making verifiable statements.
She's promoting testosterone as an add-on to standard hormone therapy. The implication is that many women might need all three hormones, not just estrogen and progesterone.
What does science say about testosterone for women?
The evidence for testosterone in postmenopausal women is actually pretty limited. The 2019 Global Consensus Position Statement on Testosterone Therapy found evidence only for treating hypoactive sexual desire disorder in postmenopausal women.
That consensus reviewed decades of research and concluded testosterone helps with sexual function but found insufficient evidence for other benefits like energy, mood, or cognitive function. The effective dose in trials was typically 300 micrograms daily of transdermal testosterone.
The North American Menopause Society's 2020 position statement echoes this. They recommend testosterone only for postmenopausal women with sexual dysfunction who haven't responded to other treatments. That's a pretty narrow indication.
What are the actual risks?
Testosterone isn't risk-free, especially for women. The 2019 consensus statement noted potential side effects including acne, hair growth, voice changes, and male-pattern baldness. Some of these effects can be permanent.
Long-term cardiovascular and breast cancer risks remain unclear. The Australian Longitudinal Study on Women's Health (Handelsman et al., 2020) found no increased cardiovascular events, but the follow-up was only 3.7 years.
The FDA hasn't approved any testosterone products for women. Doctors prescribe male formulations off-label, making dosing tricky. Too much testosterone can cause irreversible masculinizing effects.
What's missing from this conversation?
Kristina doesn't mention that testosterone deficiency in women is controversial. Unlike men, women don't have clear testosterone reference ranges for diagnosis. The Endocrine Society's 2014 guidelines actually recommend against routine testosterone testing in women.
She also skips the fact that many menopause symptoms improve with optimized estrogen and progesterone dosing. The KEEPS trial (Harman et al., 2014) showed that adjusting standard HRT often resolves persistent symptoms without adding testosterone.
Most importantly, she doesn't discuss non-hormonal options. Cognitive behavioral therapy, exercise, and sleep optimization can address many symptoms she might attribute to low testosterone.
Should you consider testosterone therapy?
If you're postmenopausal with sexual dysfunction that hasn't improved with optimized estrogen therapy, testosterone might help. But that's about where the solid evidence ends.
The key word is "optimized." Many women on HRT haven't tried different estrogen formulations, doses, or delivery methods. Transdermal estradiol often works better than oral forms for energy and mood.
Don't expect testosterone to solve non-sexual symptoms. Despite social media buzz, the evidence for testosterone improving energy, brain fog, or mood in women is weak. You might be chasing the wrong hormone entirely.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @kristina.maay's testosterone for women claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
@kristina.maay's testosterone for women claims, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Testosterone therapy for postmenopausal women has evidence only for treating hypoactive sexual desire disorder, with studies showing improvement in sexual function at 300 micrograms daily transdermal dosing.
FormBlends verdict
Testosterone therapy for postmenopausal women has evidence only for treating hypoactive sexual desire disorder, with studies showing improvement in sexual function at 300 micrograms daily transdermal dosing. The 2019 Global Consensus Position Statement found insufficient evidence for other claimed benefits like energy or mood improvement.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone therapy for postmenopausal women has evidence only for treating hypoactive sexual desire disorder, with studies showing improvement in sexual function at 300 micrograms daily transdermal dosing. The 2019 Global Consensus Position Statement found insufficient evidence for other claimed benefits like energy or mood improvement.
- Testosterone therapy for women has evidence only for treating sexual dysfunction in postmenopausal women, according to the 2019 Global Consensus Position Statement
- The effective dose in clinical trials was typically 300 micrograms daily of transdermal testosterone
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Testosterone therapy for women has evidence only for treating sexual dysfunction in postmenopausal women, according to the 2019 Global Consensus Position Statement
- The effective dose in clinical trials was typically 300 micrograms daily of transdermal testosterone
- No FDA-approved testosterone products exist for women; doctors prescribe male formulations off-label
- Side effects can include acne, hair growth, voice changes, and male-pattern baldness, some of which are permanent
- The Endocrine Society's 2014 guidelines recommend against routine testosterone testing in women due to lack of clear reference ranges
- Many persistent menopause symptoms improve with optimized estrogen and progesterone dosing before adding testosterone
- Evidence for testosterone improving energy, mood, or cognitive function in women is insufficient according to major medical societies
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Kristina.maay · TikTok creator
489.1K views on this video
I started HRT (estrogen + progesterone) almost 6 months ago but something still wasn't feeling right. I had no idea what the benefits of testosterone were until now. Let me know your thoughts on testo
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Kristina.maay, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.